Literature DB >> 9726331

Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus.

F Musio1, E M Bohen, C M Yuan, P G Welch.   

Abstract

OBJECTIVE: Thrombotic thrombocytopenic purpura (TTP) has been described in association with systemic lupus erythematosus (SLE) rarely. The diagnosis of TTP as a process separate from SLE may be difficult because both share similar features, including thrombotic microangiopathy.
METHODS: A case is described of the simultaneous occurrence of TTP and SLE. The clinical, laboratory, and histologic findings of the patient are reported. The association of TTP and SLE in the literature is analyzed. We review separately the pathogenesis, role of antiphospholipid antibodies, and the differential diagnosis of TTP complicating the course of SLE.
RESULTS: Forty cases of TTP in association with SLE are reported in the world literature. Three distinct groups were defined by the presentation of TTP that occurred subsequent to, before, or simultaneous with SLE (groups 1, 2, and 3, respectively). Renal biopsy in a patient with lupus nephritis may reveal thrombotic microangiopathy, which may be seen independently or represent a concomitant systemic thrombotic process such as TTP, disseminated intravascular coagulation, or antiphospholipid antibody syndrome.
CONCLUSION: TTP in association with SLE is rare, and the diagnosis may be challenging. Although the etiology of TTP remains elusive, certain autoimmune mechanisms, platelet abnormalities, and fibrinolytic disorders may be shared with SLE and provide the basis for their association. Management requires timely diagnosis and aggressive treatment by therapeutic plasma exchange.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9726331     DOI: 10.1016/s0049-0172(98)80023-1

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  28 in total

1.  Central retinal venous occlusion with co-existent thrombotic thrombocytopenic purpura and antiphospholipid syndrome.

Authors:  P T Murphy; P Rao
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

2.  Rapidly progressive lupus nephritis and concomitant thrombotic microangiopathy.

Authors:  Chems Gharbi; Edward Bourry; Philippe Rouvier; Sabria Hacini; Ahmed Letaief; Alain Baumelou; Hassane Izzedine
Journal:  Clin Exp Nephrol       Date:  2010-06-11       Impact factor: 2.801

3.  Acquired thrombotic thrombocytopenic purpura: puzzles, curiosities and conundrums.

Authors:  Nataliya Mar; Antonio Mendoza Ladd
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

Review 4.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

5.  Intravenous cyclophosphamide therapy in a case with refractory thrombotic microangiopathic hemolytic anemia and SLE.

Authors:  Jun Akaogi; Noriko Akasaka; Hidehiro Yamada; Nobuaki Hama; Minoru Satoh; Cody Nichols; Shoichi Ozaki
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

6.  Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura in the setting of adult-onset Still's disease.

Authors:  S Hirata; H Okamoto; S Ohta; T Kobashigawa; M Uesato; Y Kawaguchi; M Tateishi; M Hara; N Kamatani; H-M Tsai
Journal:  Rheumatology (Oxford)       Date:  2006-05-23       Impact factor: 7.580

7.  Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?

Authors:  Rina Mina; Hermine I Brunner
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

8.  Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus.

Authors:  Linnette López-López; Noridza Rivera-Rodríguez; Luis M Vilá
Journal:  BMJ Case Rep       Date:  2012-09-12

Review 9.  Pure lupus podocytopathy first presenting as thrombotic thrombocytopenic purpura-like syndrome.

Authors:  Guillermo Delgado-García; Carlos Cámara-Lemarroy; Adrián Infante-Valenzuela; Perla Colunga-Pedraza; Gabriela Alarcón-Galván; Arian Armenta-González; Héctor Jorge Villarreal-Velázquez
Journal:  Clin Rheumatol       Date:  2015-09-18       Impact factor: 2.980

Review 10.  Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies.

Authors:  G Espinosa; S Bucciarelli; R Cervera; M Lozano; J-C Reverter; G de la Red; V Gil; M Ingelmo; J Font; R A Asherson
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.